MUSK and myasthenia gravis: Exposure of myotubes to MuSK MG patient IgG4 can recapitulate pathological features of MuSK MG observed in mice injected with patient serum/IgG, such as AChR fragmentation and inhibition of MuSK phosphorylation11,28,31,32.